Bayard M, Mcintyre J, Hill KR, Woodside J. Alcohol withdrawal syndrome. Am Fam Physician. 2004;69:1443–50.
PubMed
Google Scholar
Carlson RW, Kumar NN, Wong-Mckinstry E, Ayyagari S, Puri N, Jackson FK, et al. Alcohol withdrawal syndrome. Crit Care Clin. 2012;28:549–85.
Article
PubMed
Google Scholar
Jesse S, Bråthen G, Ferrara M, Keindl M, Ben-Menachem E, Tanasescu R, et al. Alcohol withdrawal syndrome: mechanisms, manifestations, and management. Acta Neurol Scand. 2017;135:4–16.
Article
PubMed
CAS
Google Scholar
Dixit D, Endicott J, Burry L, Ramos L, Yeung S, Devabhakthuni S, et al. Management of acute alcohol withdrawal syndrome in critically ill patients. Pharmacotherapy. 2016;36:797–822.
Article
PubMed
CAS
Google Scholar
Davis KM, Wu JY. Role of glutamatergic and GABAergic systems in alcoholism. J Biomed Sci 2001;8:7–19.
Sarff M, Gold JA. Alcohol withdrawal syndromes in the intensive care unit. Crit Care Med. 2010;38(9 Suppl):S494–501.
Article
PubMed
Google Scholar
Barr J, Frasier GL, Puntillo K, Ely EW, Gélinas C, Dasta JF, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41:263–306.
Article
PubMed
Google Scholar
Umunna BP, Tekwani K, Barounis D, Kettaneh N, Kulstad E. Ketamine for continuous sedation of mechanically ventilated patients. J Emerg Trauma Shock. 2015;8:11–5.
Article
PubMed
PubMed Central
Google Scholar
Krystal JH, Petrakis IL, Krupitsky E, Schutz C, Trevisan L, D’Souza DC. NMDA receptor antagonism and the ethanol intoxication signal. from alcoholism risk to pharmacotherapy Ann N Y Acad Sci. 2003;1003:176–84.
Article
PubMed
CAS
Google Scholar
Wong A, Benedict NJ, Armahizer MJ, Kane-gill SL. Evaluation of adjunctive ketamine to benzodiazepines for management of alcohol withdrawal syndrome. Ann Pharmacother. 2015;49:14–9.
Article
PubMed
CAS
Google Scholar
Miller NS, Gold MS. Management of withdrawal syndromes and relapse prevention in drug and alcohol dependence. Am Fam Physician. 1998;58:139–46.
PubMed
CAS
Google Scholar
Sener S, Eken C, Schultz CH, Serinken M, Ozsarac M. Ketamine with and without midazolam for emergency department sedation in adults: a randomized controlled trial. Ann Emerg Med. 2011;57:109–14.
Article
PubMed
Google Scholar
Perumal DK, Adhimoolam M, Selvaraj N, Lazarus SP, Mohammed MA. Midazolam premedication for ketamine-induced emergence phenomenon: a prospective observational study. J Res Pharm Pract. 2015;4:89–93.
Article
PubMed
PubMed Central
CAS
Google Scholar
Somashekara SC, Govindadas D, Devashankaraiah G, Mahato R, Deepalaxmi S, Srinivas V, et al. Midazolam premedication in attenuating ketamine psychic sequelae. J Basic Clin Pharm. 2010;1:209–13.
PubMed
PubMed Central
CAS
Google Scholar
Kurdi MS, Theerth KA, Deva RS. Ketamine: current applications in anesthesia, pain, and critical care. Anesth Essays Res. 2014;8:283–90.
Article
PubMed
PubMed Central
Google Scholar
Liebe T, Li S, Lord A, Colic L, Krause AL, Batra A, et al. Factors influencing the cardiovascular response to subanesthetic ketamine: a randomized, placebo-controlled trial. Int J Neuropsychopharmacol 2017;1. 20:909–18.
Christ G, Mundigler G, Merhaut C, Zehetgruber M, Kratochwill C, Heinz G, et al. Adverse cardiovascular effects of ketamine infusion in patients with catecholamine-dependent heart failure. Anaesth Intensive Care. 1997;25:255–9.
PubMed
CAS
Google Scholar
Nolop KB, Natlow A. Unprecedented sedative requirements during delirium tremens. Crit Care Med. 1985;13:246–7.
Article
PubMed
CAS
Google Scholar
Woo E, Greenblatt DJ. Massive benzodiazepine requirements during acute alcohol withdrawal. Am J Psychiatry. 1979;136:821–3.
Article
PubMed
CAS
Google Scholar
Lineaweaver WC, Anderson K, Hing DN. Massive doses of midazolam infusion for delirium tremens without respiratory depression. Crit Care Med. 1988;16:294–5.
Article
PubMed
CAS
Google Scholar
Wolf KM, Shaughnessy AF, Middleton DB. Prolonged delirium tremens requiring massive doses of medication. J Am Board Fam Pract. 1993;6:502–4.
PubMed
CAS
Google Scholar
Gold JA, Rimal B, Nolan A, Nelson LS. A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens. Crit Care Med. 2007;35:724–30.
Article
PubMed
PubMed Central
CAS
Google Scholar
Kalabalik J, Sullivan JB. Use of dexmedetomidine in the management of alcohol withdrawal syndrome in critically ill patients. Int J Crit Care Emerg Med. 2015;1:002.
Article
Google Scholar
Synowiec AS, Singh DS, Yenugadhati V, Valeriano JP, Schramke CJ, Kelly KM. Ketamine use in the treatment of refractory status epilepticus. Epilepsy Res. 2013;105:183–8.
Article
PubMed
CAS
Google Scholar
Young GP, Rores C, Murphy C, Daily RH. Intravenous phenobarbital for alcohol withdrawal and convulsions. Ann Emerg Med. 1987;16:847–50.
Article
PubMed
CAS
Google Scholar
Lorentzen K, Lauritsen AØ, Bendtsen AO. Use of propofol infusion in alcohol withdrawal-induced refractory delirium tremens. Dan Med J. 2014;61:A4807.
PubMed
Google Scholar
Rayner SG, Weinert CR, Peng H, Jepsen S, Broccard AF. Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU. Ann Intensive Care. 2012;2:12.
Article
PubMed
PubMed Central
CAS
Google Scholar
Tolonen J, Rossinen J, Alho H, Harjola VP. Dexmedetomidine in addition to benzodiazepine-based sedation in patients with alcohol withdrawal delirium. Eur J Emerg Med. 2013;20:425–7.
Article
PubMed
Google Scholar